DEUTSCHE BANK AG\ - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 246 filers reported holding EDITAS MEDICINE INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$561,304
+1.3%
71,962
+6.9%
0.00%
Q2 2023$553,970
-62.2%
67,311
-66.7%
0.00%
-100.0%
Q1 2023$1,466,958
-36.5%
202,339
-22.4%
0.00%0.0%
Q4 2022$2,311,753
+148.8%
260,626
+243.2%
0.00%0.0%
Q3 2022$929,000
+3.3%
75,944
-0.1%
0.00%0.0%
Q2 2022$899,000
-41.7%
75,988
-6.3%
0.00%0.0%
Q1 2022$1,542,000
-33.5%
81,054
-7.2%
0.00%0.0%
Q4 2021$2,318,000
-38.5%
87,346
-4.8%
0.00%
-50.0%
Q3 2021$3,769,000
+41.0%
91,769
+94.4%
0.00%
+100.0%
Q2 2021$2,673,000
+4.3%
47,209
-22.7%
0.00%0.0%
Q1 2021$2,563,000
-31.1%
61,038
+15.0%
0.00%
-50.0%
Q4 2020$3,720,000
+241.9%
53,064
+36.7%
0.00%
+100.0%
Q3 2020$1,088,000
-7.6%
38,812
-2.5%
0.00%0.0%
Q2 2020$1,177,000
+166.3%
39,789
+78.4%
0.00%
Q1 2020$442,000
-93.9%
22,305
-90.9%
0.00%
-100.0%
Q4 2019$7,242,000
+28.9%
244,595
-1.0%
0.01%
+25.0%
Q3 2019$5,619,000
-22.3%
247,176
-15.5%
0.00%0.0%
Q2 2019$7,236,000
-51.5%
292,575
-52.1%
0.00%
-55.6%
Q1 2019$14,921,000
+55.1%
610,352
+44.3%
0.01%
+28.6%
Q4 2018$9,620,000
-76.8%
422,966
-67.6%
0.01%
-41.7%
Q3 2018$41,500,000
+31.1%
1,304,287
+47.6%
0.01%
+33.3%
Q2 2018$31,666,000
+92.4%
883,837
+77.9%
0.01%
+12.5%
Q1 2018$16,462,000
+268.3%
496,680
+241.3%
0.01%
+166.7%
Q4 2017$4,470,000
+78.6%
145,526
+39.5%
0.00%
+50.0%
Q3 2017$2,503,000
+249.1%
104,320
+143.8%
0.00%
+100.0%
Q2 2017$717,000
+1891.7%
42,790
+2487.1%
0.00%
Q1 2017$36,000
-50.0%
1,654
-63.6%
0.00%
Q4 2016$72,000
-91.1%
4,544
-92.5%
0.00%
-100.0%
Q3 2016$813,000
+100.7%
60,342
+262.2%
0.00%
Q2 2016$405,000
+154.7%
16,662
+261.4%
0.00%
Q1 2016$159,0004,6110.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders